{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"hsd10-disease-neonatal-type","columns":[{"gene":"","key":"population-9a17e0c7435eac4859ee","label":"HSD10 disease, neonatal type","mondoId":"MONDO:0018323","onsetQualifier":null,"originColumnKey":"MONDO:0018323/ORPHA:391457","originalViews":[{"key":"MONDO:0018323/ORPHA:391457","label":"HSD10 disease, neonatal type","scopeLabel":"ORPHA:391457","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["1028b9de8c7e9cd1e333af53b3168ba8bc5d85a42cf4bc1b2e12fdec3cd200a0","192127ee63b8157873d311a6a25662bc2f3cfe3c2fe835f169907f1aed83e725","38154318b615e3d2295df378beb3544d3a0427ffc5f9abd15c6457a464d4b177","4519e5177d6cb61bed706e43736638264cd0a05a16d4fbbd15c8f42e061945a2","533ae0867b17f35f8e4d4820319e5ea40d81917b9e76726a7bee00e9b8c0d80a","5c0181480fd719cae15164c82ebbd134c7a4fc6f7b04387d9e5dc01823e66ac1","94116c29fa9d6d2a09f1d8485752b0d5bb6f510126939b2235032cdb51aada4d","c4d61ed6cae2441de9b410f8b6fbf5ec1e394a786e6d10d5ad3c142b2ab1d0e5","f71e67715e9a0ca5d3a4a245e0a706bbb941425aa6df93b0d74ccb22a0f85d94"],"recordQualifiers":{},"scopeLabel":"ORPHA:391457","sourceIds":["ORPHA:391457"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-9a17e0c7435eac4859ee"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012379","HP:0500170","HP:0003256","HP:0001392","HP:0001263","HP:0001639","HP:0003128"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":9,"sourceGroups":{"orphanet":9}},"features":[{"hpoId":"HP:0012379","label":"Abnormal circulating enzyme concentration or activity","primary":true},{"hpoId":"HP:0500170","label":"Abnormal concentration of acylcarnitine in the urine","primary":true},{"hpoId":"HP:0003256","label":"Abnormality of the coagulation cascade","primary":true},{"hpoId":"HP:0001392","label":"Abnormality of the liver","primary":true},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":true},{"hpoId":"HP:0001639","label":"Hypertrophic cardiomyopathy","primary":true},{"hpoId":"HP:0003128","label":"Lactic acidosis","primary":true},{"hpoId":"HP:0001942","label":"Metabolic acidosis","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false}],"ledeHtml":"HSD10 disease, neonatal type is the most severe form of HSD10 disease, a rare neurometabolic disorder. It is characterized by onset of severe metabolic/lactic acidosis, neurological and psychomotor delay, seizures and severe progressive hypertrophic cardiomyopathy in the neonatal period. Hepatic involvement and coagulopathy are rare. The disease is fatal within the first months of life.","mondoId":"MONDO:0018323","node":{"canonicalSlug":"hsd10-disease-neonatal-type","comparisons":[{"documentSha256":"c2c3f2a2ca5c2d1ecddc3777472d262f2b2452acfb80c65541f52b0d1b7e8df2","key":"legacy-hsd10-disease","kind":"legacy","label":"HSD10 mitochondrial disease","memberIds":["MONDO:0010327","MONDO:0018322","MONDO:0018323","MONDO:0037149"],"mondoId":"MONDO:0010327","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/hsd10-disease.c2c3f2a2ca5c2d1ecddc3777472d262f2b2452acfb80c65541f52b0d1b7e8df2.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"HSD10 disease, neonatal type","paragraphs":["HSD10 disease, neonatal type is the most severe form of HSD10 disease, a rare neurometabolic disorder. It is characterized by onset of severe metabolic/lactic acidosis, neurological and psychomotor delay, seizures and severe progressive hypertrophic cardiomyopathy in the neonatal period. Hepatic involvement and coagulopathy are rare. The disease is fatal within the first months of life."],"scope":"exact","source":"MONDO","upstream":"Orphanet:391457","url":"https://monarchinitiative.org/MONDO:0018323"},"ownColumnKeys":["population-9a17e0c7435eac4859ee"],"publication":"published","relationships":[{"kind":"parent","label":"HSD10 mitochondrial disease","mondoId":"MONDO:0010327","slug":"hsd10-disease"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/17623"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"1028b9de8c7e9cd1e333af53b3168ba8bc5d85a42cf4bc1b2e12fdec3cd200a0","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:391457","disease_name":"HSD10 disease, neonatal type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0003256","is_excluded":false,"label":"Abnormality of the coagulation cascade","onset_id":null,"reference":"ORPHA:391457","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"192127ee63b8157873d311a6a25662bc2f3cfe3c2fe835f169907f1aed83e725","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:391457","disease_name":"HSD10 disease, neonatal type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0012379","is_excluded":false,"label":"Abnormal circulating enzyme concentration or activity","onset_id":null,"reference":"ORPHA:391457","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"38154318b615e3d2295df378beb3544d3a0427ffc5f9abd15c6457a464d4b177","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:391457","disease_name":"HSD10 disease, neonatal type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:391457","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4519e5177d6cb61bed706e43736638264cd0a05a16d4fbbd15c8f42e061945a2","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:391457","disease_name":"HSD10 disease, neonatal type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0500170","is_excluded":false,"label":"Abnormal concentration of acylcarnitine in the urine","onset_id":null,"reference":"ORPHA:391457","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"533ae0867b17f35f8e4d4820319e5ea40d81917b9e76726a7bee00e9b8c0d80a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:391457","disease_name":"HSD10 disease, neonatal type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001942","is_excluded":false,"label":"Metabolic acidosis","onset_id":null,"reference":"ORPHA:391457","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5c0181480fd719cae15164c82ebbd134c7a4fc6f7b04387d9e5dc01823e66ac1","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:391457","disease_name":"HSD10 disease, neonatal type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003128","is_excluded":false,"label":"Lactic acidosis","onset_id":null,"reference":"ORPHA:391457","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"94116c29fa9d6d2a09f1d8485752b0d5bb6f510126939b2235032cdb51aada4d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:391457","disease_name":"HSD10 disease, neonatal type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"ORPHA:391457","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c4d61ed6cae2441de9b410f8b6fbf5ec1e394a786e6d10d5ad3c142b2ab1d0e5","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:391457","disease_name":"HSD10 disease, neonatal type","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001392","is_excluded":false,"label":"Abnormality of the liver","onset_id":null,"reference":"ORPHA:391457","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f71e67715e9a0ca5d3a4a245e0a706bbb941425aa6df93b0d74ccb22a0f85d94","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:391457","disease_name":"HSD10 disease, neonatal type","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001639","is_excluded":false,"label":"Hypertrophic cardiomyopathy","onset_id":null,"reference":"ORPHA:391457","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018323\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>Orphanet:391457</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>HSD10 disease, neonatal type is the most severe form of HSD10 disease, a rare neurometabolic disorder. It is characterized by onset of severe metabolic/lactic acidosis, neurological and psychomotor delay, seizures and severe progressive hypertrophic cardiomyopathy in the neonatal period. Hepatic involvement and coagulopathy are rare. The disease is fatal within the first months of life.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0018323\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"hsd10-disease-neonatal-type","sourceDocuments":[{"name":"MONDO: HSD10 disease, neonatal type","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0018323"}],"sourceNote":"","synonyms":["2-methyl-3-hydroxybutyric aciduria, neonatal type","2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, neonatal type","HSD10 deficiency, neonatal type","MHBD deficiency, neonatal type"],"takeawayHtml":"","title":"HSD10 disease, neonatal type"},"schemaVersion":1}
